首页 | 本学科首页   官方微博 | 高级检索  
检索        

加味四妙丸联合青敷贴敷治疗慢性肾脏病急性痛风性关节炎临床研究
引用本文:朱羿霖,盛梅笑,江燕,陶兴,刘利华.加味四妙丸联合青敷贴敷治疗慢性肾脏病急性痛风性关节炎临床研究[J].山东中医杂志,2019(2):129-134.
作者姓名:朱羿霖  盛梅笑  江燕  陶兴  刘利华
作者单位:江苏省中医院
摘    要:目的:观察加味四妙丸联合青敷贴敷治疗慢性肾脏病急性痛风性关节炎的临床疗效。方法:选取53例符合要求的患者,随机分为治疗组32例和对照组21例。在低嘌呤饮食、碱化尿液、酌情使用非甾体类抗炎药及延缓肾功能进展等西医治疗基础上,治疗组予内服加味四妙丸联合青敷贴敷治疗,对照组予内服加味四妙丸。以1周为1个观察周期,观察3~4个周期,于治疗前后记录关节疼痛及功能评分(VAS视觉疼痛评分、关节肿痛指数、关节功能评分)、物理指标(肿痛关节周径、肿痛关节皮温)、炎症指标(超敏C反应蛋白、白细胞计数、中性粒细胞百分比)、肾功能指标(血尿酸、尿素氮、肌酐)及安全性指标(血清门冬氨酸氨基转移酶、血清丙氨酸氨基转移酶、血小板计数)。结果:①总有效率治疗组96.86%,对照组90.48%,两组疗效相当(P 0.05);②平均疗程治疗组(7.81±3.27) d,对照组(11.33±6.04) d,治疗组疗程短于对照组(P0.05);③两组治疗后关节疼痛及功能评分均较治疗前下降(P0.01),且治疗组优于对照组(P0.05);④两组治疗后物理指标均较治疗前下降(P0.01),治疗组优于对照组(P0.01);⑤两组治疗后炎症指标、血小板计数、血尿素氮均较治疗前改善(P0.01,P0.05)。结论:加味四妙丸联合青敷贴敷治疗能较好地缓解慢性肾脏病急性痛风性关节炎患者关节肿痛症状,缩短疗程,安全性较好。

关 键 词:慢性肾脏病  痛风急性发作  湿热痹络证  加味四妙丸  青敷  疼痛及功能评价  物理指标  炎症指标  肾功能  安全性

Clinical Study of the Therapeutic Effect of Jiawei Simiao Pill Combined with Qingfu Pasting on Patients with Chronic Kidney Disease Accompanied with Acute Gouty Arthritis
Institution:,Jiangsu Provincial Hospital of Traditional Chinese Medicine
Abstract:Objective:To observe the clinical efficacy of Jiawei Simiao pill combined with Qingfu pasting in the treatment of acute gouty arthritis. Methods:Fifty three patients meeting the criteria were randomly divided into the treatment group(32 patients) and the control group(21 patients). Besides the low-purine diet,alkalizing urine,applying non-steroidal anti-inflammatory drugs depending on the disease condition,and delaying the progression of renal failure and other western medicine routine treatment,the treatment group was treated with Jiawei Simiao pill combined with Qingfu pasting,and the control group was only given oral administration of Jiawei Simiao pill.One week was used as an observation period,and patients were observed for 3 to 4 periods. Joint pain and functional scores(visual pain score(VAS),joint swelling and pain index,joint function score) and physical indexes(circumference and skin temperature of the swelling and painful joint),inflammation index(high-sensitivity C-reactive protein,white blood cell count,percentage of neutrophils),renal function index(serum uric acid,urea nitrogen,creatinine) and safety indicators(serum aspartate aminotransferase,serum gluten transaminase,platelet count) were recorded before and after treatment. Results:①Total effective rate was 96.86% in the treatment group and 90.48% in the control group,with no statistical difference(P> 0.05);②The average course lasted in the treatment group for 7.81±3.27 days,while in the control group lasted for 11.33±6.04 days,and the treatment group was shorter than the control group on treatment course(P<0.05). ③On pain and functional scores after treatment the two groups were lower than before treatment(P<0.01),and the treatment group was superior to the control group(P<0.05). ④On the physical indexes after treatment both groups were lower than before treatment(P<0.01),and the treatment group was better than the control group(P<0.01). ⑤The inflammation index,platelet count and blood urea nitrogen were improved after treatment(P<0.01,P<0.05). Conclusion:Jiawei Simiao pill combined with Qingfu pasting can obviously alleviate the symptoms of joint swelling and pain in patients with chronic kidney disease accompanied with acute gouty arthritis,and shorten the course of treatment with high safety.
Keywords:chronic kidney disease  acute gout attack  damp-heat impeding collaterals syndrome  Jiawei Simiao pill  Qingfu  pain and function evaluation  physical indicators  inflammation index  renal function  safety
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号